Jake Micheal Gazeley

Mr. Jake Micheal Gazeley

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
BLBinit Lamichhane
Binit Lamichhane
CMCara A Minney-Smith
Cara A Minney-Smith
JGJake Micheal Gazeley
Jake Micheal Gazeley
UWUshma Wadia
Ushma Wadia
DFDavid A Foley
David A Foley
ALAvram Levy
Avram Levy
Background: Nirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During the 2024 RSV season in Western Australia, 21 922 doses were administered to infants entering their first season and 1221 doses to at-risk children. In this context, the selection and spread of escape variants are a potential concern. This study aimed to investigate nirsevimab binding site mutations using clinical and wastewater data. Methods: We performed whole genome sequencing on 382 clinical RSV samples and 12 wastewater samples collected between September 2023 and October 2024. RSV subtypes, genetic diversity, and mutations within the nirsevimab binding region of the F protein were analyzed. Phylogenetic analysis was conducted to assess lineage dynamics and the potential emergence of escape variants. Results: RSV-A was the dominant subtype (61.8%), with RSV-B accounting for 38.2% of cases. No lineage shifts were observed following nirsevimab introduction, and none of the known mutations associated with high-level nirsevimab resistance were detected in either clinical or wastewater samples. The prevalent RSV-B mutation combination (F:I206M:Q209R:S211N) was observed consistently but is not associated with reduced nirsevimab efficacy. Wastewater sampling, covering approximately 2 million people from the Perth metropolitan region, confirmed findings from clinical sequences, reinforcing the absence of resistance mutations. Conclusions: No evidence of nirsevimab escape mutations was found in clinical or wastewater samples during the 2024 RSV season. Continued genomic surveillance, including wastewater monitoring, is essential to detect emerging resistance and ensure the long-term efficacy of prophylactic interventions.

8 April 2025 in Environments
Verified
Journal Article
Open access
PDF file
ALAvram Levy
Avram Levy
C(Christina Crachi (Simpkins)
Christina Crachi (Simpkins)
JGJake Micheal Gazeley
Jake Micheal Gazeley
JCJoanne R Chapman
Joanne R Chapman
ABAnna Brischetto
Anna Brischetto
TAThe Wastewater Surveillance Working Group, Communicable Diseases Genomics Network of Australia
The Wastewater Surveillance Working Group, Communicable Diseases Genomics Network of Australia
Wastewater pathogen surveillance was rapidly implemented across Australia and New Zealand as a public health tool during the COVID-19 pandemic. To assess method consistency and identify opportunities for harmonization, we surveyed all Australian and New Zealand Laboratories conducting government-funded wastewater pathogen surveillance. The survey demonstrated alignment of some method choices, particularly municipal wastewater treatment plant (WWTP) sampling and the use of electromagnetic membrane filtration followed by RT-qPCR. However, key differences were observed in the wastewater sample volumes; nucleic acid purification methods; validation approaches; and sequencing, analysis, and reporting methods for SARS-CoV-2 lineages. A lack of consensus on best-practice methods was evident, highlighting the need for interlaboratory sample and data exchanges to support validation and comparability. Following the pandemic period, several jurisdictional programs were discontinued despite the mounting international evidence for the utility of wastewater-based epidemiology for a range of pathogens. Subsequently, a nationally funded program was announced in Australia, necessitating the re-establishment of laboratory capacity for some jurisdictions and expansion of target pathogens for other centers. The results of this survey are intended to inform the re-establishment and enhancement of regional capacity and to provide a foundation for best-practice knowledge sharing and approach harmonization.

24 March 2024 in Environments
Verified
Journal Article
Open access
PDF file
JGJake Micheal Gazeley
Jake Micheal Gazeley
TLTerence Lee
Terence Lee
DKDaniel R. Knight
Daniel R. Knight
ASAlexander Shivarev
Alexander Shivarev
CGCameron Gordon
Cameron Gordon
ALAvram Levy
Avram Levy
Wastewater-based epidemiology (WBE) has emerged as a key method for the continuous monitoring of COVID-19 prevalence including circulating SARS-CoV-2 lineages. WBE addresses the limitations of traditional clinical COVID-19 surveillance such as clinical test availability, fluctuating testing rates, and increased reliance on rapid antigen tests. Our study in Perth, Western Australia found a significant positive correlation between SARS-CoV-2 concentrations in wastewater and clinical PCR positivity rates (rs = 0.772; p < 0.001) over an 18-month period that included four successive COVID-19 waves. A strong positive correlation was apparent between the proportions of SARS-CoV-2 lineages in wastewater and clinical cases within the same region (rs = 0.728, p < 0.001), including earlier detection of Omicron and recombinant lineages in wastewater before clinical case confirmation. The successful integration of WBE with healthcare data underscores its critical role in enhancing public health decision-making and pandemic management. This approach not only demonstrates the value of WBE in current global health surveillance efforts but also highlights the potential of WBE to address future public health challenges, as a comprehensive disease monitoring and response approach.

5 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JGJake Micheal Gazeley
Jake Micheal Gazeley
TLTerence Lee
Terence Lee
DKDaniel R Knight
Daniel R Knight
ASAlexander Shivarev
Alexander Shivarev
CGCameron Gordon
Cameron Gordon
ALAvram Levy
Avram Levy
Wastewater-based epidemiology (WBE) has emerged as a key method for continuous monitoring of COVID-19 prevalence including circulating SARS-CoV-2 lineages. WBE addresses limitations of traditional clinical COVID-19 surveillance such as clinical test availability, fluctuating testing rates and increased reliance on rapid antigen tests. Our study in Perth, Western Australia, found a significant positive correlation between SARS-CoV-2 concentrations in wastewater and clinical PCR positivity rates (rs = 0.772; p < 0.001) over an 18-month period that included four successive COVID-19 waves. A strong positive correlation was apparent between the proportions of SARS-CoV-2 lineages in wastewater and clinical cases within the same region (rs = 0.728; p < 0.001), including earlier detection of Omicron and recombinant lineages in wastewater before clinical case confirmation. The successful integration of WBE with healthcare data underscores its critical role in enhancing public health decision-making and pandemic management. This approach not only demonstrates the value of WBE in current global health surveillance efforts but also highlights the potential of WBE to address future public health challenges, as a comprehensive disease monitoring and response approach.

25 October 2021 in OSF Preprints
Verified
Preprint
Open access
ALAvram Levy
Avram Levy
JGJake Micheal Gazeley
Jake Micheal Gazeley
TLTerence Lee
Terence Lee
AJAndrew Jardine
Andrew Jardine
CGCameron Gordon
Cameron Gordon
DSDavid Speers
David Speers
After a limited first wave of community transmission in March 2020, Western Australia has remained largely free of COVID-19, with cases restricted to hotel quarantine, commercial vessels, and small, infrequent community clusters. Despite so few cases, whole genome sequencing (WGS) of SARS-CoV-2 from wastewater of large municipal treatments plants yielded genomic coverage up to 98% with sufficient depth to link wastewater to the WGS sequences of active cases in the catchment at the time. WGS analysis of wastewater contemporaneous with clinical cases can also be used to rule out transmission between cases in different catchments, when their SARS-CoV-2 genomes differ. These findings reveal a greater potential of wastewater WGS to inform outbreak control and disease surveillance than previously recognized.